The Dana-Farber Cancer Institute at Londonderry is a clinical research site located in Londonderry, New Hampshire, United States 03053.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
The Dana-Farber Cancer Institute at Londonderry has participated in 23 clinical trials with 15 currently active.
Therapeutic areas: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.
Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The Dana-Farber Cancer Institute at Londonderry has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Dana-Farber Cancer Institute at Londonderry has 23 clinical trials on record, with 15 currently active. Their work covers Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.
Yes — The Dana-Farber Cancer Institute at Londonderry holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.